Literature DB >> 19403709

The effect of high-fructose corn syrup consumption on triglycerides and uric acid.

Theodore J Angelopoulos1, Joshua Lowndes, Linda Zukley, Kathleen J Melanson, Von Nguyen, Anik Huffman, James M Rippe.   

Abstract

Rates of overweight and obesity have been on a steady rise for decades, and the problems society faces from this and associated metabolic diseases are many. As a result, the need to understand the contributing factors is great. A very compelling case can be made that excess sugar consumption has played a significant role. In addition, fructose, as a component of the vast majority of caloric sweeteners, is seen to be particularly insidious. Evidence shows that fructose bypasses many of the body's satiating signals, thus potentially promoting overconsumption of energy, weight gain, and the development on insulin resistance. It has also been shown to increase uric acid levels, which in turn promotes many of the abnormalities seen in the metabolic syndrome including hypertriglyceridemia. However, the main source of fructose in the diet is high-fructose corn syrup (HFCS), an artificially manufactured disaccharide that is only 55% fructose. This review highlights the fact that limited data are available about the metabolic effects of HFCS compared with other caloric sweeteners. The data suggest that HFCS yields similar metabolic responses to other caloric sweeteners such as sucrose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403709     DOI: 10.3945/jn.108.098194

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  26 in total

1.  Acute effect of fructose intake from sugar-sweetened beverages on plasma uric acid: a randomised controlled trial.

Authors:  E L Carran; S J White; A N Reynolds; J J Haszard; B J Venn
Journal:  Eur J Clin Nutr       Date:  2016-06-22       Impact factor: 4.016

2.  Fructose intake and cardiovascular risk factors in youth with type 1 diabetes: SEARCH for diabetes in youth study.

Authors:  Sarah C Couch; Jamie L Crandell; Amy S Shah; Lawrence M Dolan; Anwar T Merchant; Angela D Liese; Jean M Lawrence; Catherine Pihoker; Elizabeth J Mayer-Davis
Journal:  Diabetes Res Clin Pract       Date:  2013-03-27       Impact factor: 5.602

Review 3.  Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression.

Authors:  Richard C Shelton; Andrew H Miller
Journal:  Prog Neurobiol       Date:  2010-04-22       Impact factor: 11.685

Review 4.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 5.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

6.  Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans.

Authors:  Kimber L Stanhope; Peter J Havel
Journal:  J Nutr       Date:  2009-04-29       Impact factor: 4.798

7.  Dietary fructose and metabolic syndrome and diabetes.

Authors:  John P Bantle
Journal:  J Nutr       Date:  2009-04-29       Impact factor: 4.798

Review 8.  Dietary fructose and glucose differentially affect lipid and glucose homeostasis.

Authors:  Ernst J Schaefer; Joi A Gleason; Michael L Dansinger
Journal:  J Nutr       Date:  2009-04-29       Impact factor: 4.798

9.  Fructose-containing sugars do not raise blood pressure or uric acid at normal levels of human consumption.

Authors:  Mark Houston; Deanna M Minich
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-10       Impact factor: 3.738

10.  Binahong (Anredera cordifolia (Tenore) Steen.) Leaf Extract Modulates Fatty Acids and Amino Acids to Lower Blood Glucose in High-Fat Diet-Induced Diabetes Mellitus Rats.

Authors:  Dwitiyanti Dwitiyanti; Yahdiana Harahap; Berna Elya; Anton Bahtiar
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.